- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
(Richmond, VA) - Yesterday, the Virginia Senate by a vote of 37 to 2 passed SB701, a bill that would allow the production and manufacturing of cannabidiol (CBD) oil and THC-A oil in the state. For the past several weeks, patients, parents and advocates from across the state worked tirelessly to persuade members of the Senate to move forward on this issue, which until last year seemed out of reach for Virginia's conservative legislature.
Last year’s passage of SB1235 and HB1445 gave intractable epilepsy patients and their caregivers an affirmative defense for possession of two marijuana oils, THCa and CBD, used to treat seizures. However, the law provides no way for patients to obtain the oils without breaking federal and state laws. To help rectify this situation, Senator Marsden from Fairfax introduced SB701, which, if passed, will provide a mechanism for production in the state of these oils for patients with intractable epilepsy.
“Patients and their families undergo incredible daily stress managing uncontrolled seizures. Breaking laws to obtain this treatment is an additional stressor these families do not need. Yesterday’s vote is a just another small victory towards ensuring these patients have safe, reliable access to this treatment,” said Beth Collins, ASA director of communications and outreach. “The passage of SB701 would have a dramatic impact on the lives of patients by further expanding the medical cannabis program to allow access to low-THC extracts within the state of Virginia.”
Virginia is one of 40 states with medical marijuana laws but, as detailed in ASA’s latest report on Medical Cannabis Access in the U.S., is one of the seventeen states that limits use to CBD and THCa oils for certain conditions. With the passage of SB 701, Virginia could drastically improve the state’s failing grade on medical cannabis access.
Advocates plan to return to the General Assembly early next week to begin lobbying key legislators in the House.